Canada · Delayed Price · Currency is CAD Sanofi Statistics
Total Valuation
Sanofi has a market cap or net worth of CAD 136.56 billion. The enterprise value is 164.73 billion.
| Market Cap | 136.56B |
| Enterprise Value | 164.73B |
Important Dates
The next confirmed earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | May 6, 2026 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.54% |
| Shares Change (QoQ) | -0.63% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 42.90% |
| Float | 1.08B |
Valuation Ratios
The trailing PE ratio is 21.10 and the forward PE ratio is 8.00.
| PE Ratio | 21.10 |
| Forward PE | 8.00 |
| PS Ratio | 1.71 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 9.36 |
| P/FCF Ratio | 8.32 |
| P/OCF Ratio | 7.06 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.53, with an EV/FCF ratio of 10.05.
| EV / Earnings | 25.49 |
| EV / Sales | 2.09 |
| EV / EBITDA | 7.53 |
| EV / EBIT | 10.10 |
| EV / FCF | 10.05 |
Financial Position
The company has a current ratio of 0.99, with a Debt / Equity ratio of 0.34.
| Current Ratio | 0.99 |
| Quick Ratio | 0.49 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 1.71 |
| Debt / FCF | 2.35 |
| Interest Coverage | 17.08 |
Financial Efficiency
Return on equity (ROE) is 5.71% and return on invested capital (ROIC) is 9.12%.
| Return on Equity (ROE) | 5.71% |
| Return on Assets (ROA) | 5.09% |
| Return on Invested Capital (ROIC) | 9.12% |
| Return on Capital Employed (ROCE) | 10.66% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 1.06M |
| Profits Per Employee | 85,796 |
| Employee Count | 74,846 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 1.25 |
Taxes
In the past 12 months, Sanofi has paid 1.95 billion in taxes.
| Income Tax | 1.95B |
| Effective Tax Rate | 23.16% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 19.57 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 35.37 |
| Average Volume (20 Days) | 909 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sanofi had revenue of CAD 79.37 billion and earned 6.42 billion in profits. Earnings per share was 5.30.
| Revenue | 79.37B |
| Gross Profit | 58.30B |
| Operating Income | 16.79B |
| Pretax Income | 8.43B |
| Net Income | 6.42B |
| EBITDA | 21.97B |
| EBIT | 16.79B |
| Earnings Per Share (EPS) | 5.30 |
Balance Sheet
The company has 10.30 billion in cash and 38.25 billion in debt, with a net cash position of -27.95 billion.
| Cash & Cash Equivalents | 10.30B |
| Total Debt | 38.25B |
| Net Cash | -27.95B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 112.87B |
| Book Value Per Share | 93.72 |
| Working Capital | -661.95M |
Cash Flow
In the last 12 months, operating cash flow was 19.21 billion and capital expenditures -2.92 billion, giving a free cash flow of 16.29 billion.
| Operating Cash Flow | 19.21B |
| Capital Expenditures | -2.92B |
| Depreciation & Amortization | 5.11B |
| Net Borrowing | -353.64M |
| Free Cash Flow | 16.29B |
| FCF Per Share | n/a |
Margins
Gross margin is 73.45%, with operating and profit margins of 21.16% and 8.09%.
| Gross Margin | 73.45% |
| Operating Margin | 21.16% |
| Pretax Margin | 10.62% |
| Profit Margin | 8.09% |
| EBITDA Margin | 27.68% |
| EBIT Margin | 21.16% |
| FCF Margin | 20.81% |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 4.39%.
| Dividend Per Share | 0.80 |
| Dividend Yield | 4.39% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 124.38% |
| FCF Payout Ratio | n/a |
| Buyback Yield | 2.54% |
| Shareholder Yield | 6.93% |
| Earnings Yield | 4.74% |
| FCF Yield | 12.02% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |